Gut Microbiota and Bile Acids: Metabolic Interactions and Impacts on Diabetic Kidney Disease

Ping Liu,Meiping Jin,Ping Hu,Weiqian Sun,Yuyan Tang,Jiajun Wu,Dongliang Zhang,Licai Yang,Haidong He,Xudong Xu
DOI: https://doi.org/10.1016/j.crmicr.2024.100315
2024-01-01
Current Research in Microbial Sciences
Abstract:The intestinal microbiota comprises approximately 1013–1014 species of bacteria and plays a crucial role in host metabolism by facilitating various chemical reactions. Secondary bile acids (BAs) are key metabolites produced by gut microbiota.Initially synthesized by the liver, BA undergoes structural modifications through the activity of various intestinal microbiota enzymes, including eukaryotic, bacterial, and archaeal enzymes. These modified BA then activate specific receptors that regulate multiple metabolic pathways in the host, such as lipid and glucose metabolism, energy balance, inflammatory response, and cell proliferation and death. Recent attention has been given to intestinal flora disorders in diabetic kidney disease (DKD), where activation of BA receptors has shown promise in alleviating diabetic kidney damage by modulating renal lipid metabolism and mitochondrial production. Imbalances in the intestinal flora can influence the progression of DKD through the regulation of bile acid and its receptor pathways. This review aims to propose a mechanism involving the gut-BA-diabetes and nephropathy axes with the goal of optimizing new strategies for treating DKD.
What problem does this paper attempt to address?